D-0182-2027 Class II Ongoing
FDA drug recall D-0182-2027 was initiated by Advagen Pharma Limited on Oct 27, 2026 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules The recall status is ongoing. Affected quantity: 3684 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 11, 2026
- Initiation Date
- Oct 27, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3684 bottles
Product description
Metoprolol Tartrate Tablets, USP, 50 mg, 1,000 Tablets per bottle, Rx Only, Distributed by: Advagen Pharma Ltd., East Windsor, NJ 08520, USA. NDC: 72888-210-00.
Reason for recall
Presence of Foreign Tablets/Capsules
Distribution pattern
U.S. Nationwide
Code information
Batch#: 2611C065A1: Expiry: 05/2028
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0182-2027
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Advagen Pharma Limited? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.